PATENT CLAIM ANALYSIS

Application Number: 16106123
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "417000"]

Abstract:
Present invention relates to a topical pharmaceutical composition of apremilast or its pharmaceutical acceptable salts in range of 0.01 to 25% w/w, isopropyl myristate and optionally with one or more pharmaceutically acceptable excipients and process for the preparation thereof. Further, topical formulations of this invention are therefore suitable for the treatment of psoriasis and psoriatic arthritis and they may also be used with some other medicaments.

Claim (Index 1):
Topical pharmaceutical composition of apremilast comprising apremilast and its pharmaceutical acceptable salts in range of 0.01 to 25% w/w, isopropyl myristate and optionally with other pharmaceutically acceptable excipients.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 96.0
- Lexical Diversity: 1.31481
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15848462', '14626137', '15226684', '16054353', '13580129']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.648887750788137
- 35 USC 102 Novelty (BERT): 0.5028771361030038
- Combined Prediction Score: 0.6342866893196237
- Mean Citation Score: 222.96463
- Max Citation Score: 229.12608
- Similarity Product: 151.23130374040605

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test